People walk past a CVS pharmacy store in the Manhattan neighborhood of New York City.
Shannon Stapleton | Reuters
CVS Health announced Monday that it would offer three over-the-counter Covid-19 tests in its drugstores as well as online to expand access to home testing as the US accelerates vaccine adoption.
The company said the tests include a home test from Australian diagnostic test maker Ellume, Abbott Laboratories’ BinaxNOW antigen self-test, and LabCorp’s home collection kits, all of which do not require a prescription and can be used by people with or without symptoms.
The move comes at a time when schools and offices in the US are increasingly seeking physical surgery again as the country intensifies its vaccination campaign. CVS is the first drug dealer to offer the Ellume test. The company said the test will be available in select pharmacy locations in Rhode Island and Massachusetts starting this week, and at CVS.com and most pharmacies starting in late May.
The Abbott self-test, which was recently approved by the US, and LabCorp’s test kits are available online and at some pharmacies, according to CVS.
Rival Walgreens Boots Alliance, which partnered with CVS with the federal government to vaccinate residents of U.S. nursing homes through a voluntary program, has also been selling LabCorp test kits since earlier this month.
The Ellume and Abbott tests can give results in 15 minutes while the LabCorp test gives results in a day or two.